Literature DB >> 8344316

Docking the mitochondrial inhibitor protein IF1 to a membrane receptor different from the F1-ATPase beta subunit.

C Lopez-Mediavilla1, H Vigny, C Godinot.   

Abstract

Monoclonal antibodies reacting with the inhibitor protein (IF1) of the mitochondrial ATPase/ATP synthase complex did not modify the IF1-induced inhibition of soluble F1 ATPase activity. On the contrary, they increased the ATPase activity of inverted electron-transport particles without inducing a significant release of IF1 from these particles. This suggested that IF1 could be linked to a membrane protein when it was not inhibiting the ATPase activity. IF1 antibodies have been used to show that IF1 can bind not only to the beta subunit of F1-ATPase [Klein, G., Satre, M., Dianoux, A. C. & Vignais, P. V. (1981) Biochemistry 20, 1339-1344] but also to a protein present in the inner-mitochondrial membrane. The cross-linking of IF1 to this membrane protein gave a product of M(r) 15000-16000 that migrated differently from IF1 and from the dimer of IF1 using SDS/PAGE. When the cross-linked product was obtained by using a cleavable cross-linking reagent, the complex between IF1 and the docking protein was partly dissociated and free IF1 was recovered. Considering the molecular mass of IF1, this docking protein for IF1 has apparent M(r) 5000-6000. The complex between IF1 and this receptor protein can be detected in low amounts by antibodies against IF1 in the absence of cross-linking reagent. Since this complex remained in the pellet after treatment of the membrane with Triton X-100, it should be a membrane protein. Therefore, IF1 can bind not only to its inhibitory-binding site at the beta subunit of F1, but also to a non inhibitory site which is a membrane protein of approximate M(r) 5000-6000.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8344316     DOI: 10.1111/j.1432-1033.1993.tb18058.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  11 in total

1.  The inhibitor protein (IF1) of the F1F0-ATPase modulates human osteosarcoma cell bioenergetics.

Authors:  Simona Barbato; Gianluca Sgarbi; Giulia Gorini; Alessandra Baracca; Giancarlo Solaini
Journal:  J Biol Chem       Date:  2015-01-20       Impact factor: 5.157

2.  Cross-linking of the endogenous inhibitor protein (IF1) with rotor (gamma, epsilon) and stator (alpha) subunits of the mitochondrial ATP synthase.

Authors:  Fernando Minauro-Sanmiguel; Concepción Bravo; José J García
Journal:  J Bioenerg Biomembr       Date:  2002-12       Impact factor: 2.945

3.  Myocardial ischemic preconditioning and mitochondrial F1F0-ATPase activity.

Authors:  F Bosetti; G Yu; R Zucchi; S Ronca-Testoni; G Solaini
Journal:  Mol Cell Biochem       Date:  2000-12       Impact factor: 3.396

4.  Modification of the mitochondrial F1-ATPase epsilon subunit, enhancement of the ATPase activity of the IF1-F1 complex and IF1-binding dependence of the conformation of the epsilon subunit.

Authors:  G Solaini; A Baracca; E Gabellieri; G Lenaz
Journal:  Biochem J       Date:  1997-10-15       Impact factor: 3.857

5.  In vivo inhibition of the mitochondrial H+-ATP synthase in neurons promotes metabolic preconditioning.

Authors:  Laura Formentini; Marta P Pereira; Laura Sánchez-Cenizo; Fulvio Santacatterina; José J Lucas; Carmen Navarro; Alberto Martínez-Serrano; José M Cuezva
Journal:  EMBO J       Date:  2014-02-12       Impact factor: 11.598

6.  IEX-1 targets mitochondrial F1Fo-ATPase inhibitor for degradation.

Authors:  L Shen; L Zhi; W Hu; M X Wu
Journal:  Cell Death Differ       Date:  2008-12-19       Impact factor: 15.828

7.  The serum- and glucocorticoid-induced protein kinase-1 (Sgk-1) mitochondria connection: identification of the IF-1 inhibitor of the F(1)F(0)-ATPase as a mitochondria-specific binding target and the stress-induced mitochondrial localization of endogenous Sgk-1.

Authors:  Bridget A O'Keeffe; Salvatore Cilia; Anita C Maiyar; Maria Vaysberg; Gary L Firestone
Journal:  Biochimie       Date:  2013-02-08       Impact factor: 4.079

8.  Overexpression, purification, and characterization of human and bovine mitochondrial ATPase inhibitors: comparison of the properties of mammalian and yeast ATPase inhibitors.

Authors:  Naoki Ichikawa; Chikae Ogura
Journal:  J Bioenerg Biomembr       Date:  2003-10       Impact factor: 2.945

9.  The native F0F1-inhibitor protein complex from beef heart mitochondria and its reconstitution in liposomes.

Authors:  E Vázquez-Contreras; N Vázquez-Laslop; G Dreyfus
Journal:  J Bioenerg Biomembr       Date:  1995-02       Impact factor: 2.945

10.  Expression, regulation and clinical relevance of the ATPase inhibitory factor 1 in human cancers.

Authors:  M Sánchez-Aragó; L Formentini; I Martínez-Reyes; J García-Bermudez; F Santacatterina; L Sánchez-Cenizo; I M Willers; M Aldea; L Nájera; A Juarránz; E C López; J Clofent; C Navarro; E Espinosa; J M Cuezva
Journal:  Oncogenesis       Date:  2013-04-22       Impact factor: 7.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.